Dr. Miller is Executive Director of Global Nexus, and Scientific Director of the M.G. DeGroote Institute for Infectious Disease Research at McMaster University. He also serves as Co-Director of Canadian Pandemic Preparedness Hub (CP2H). Dr. Miller holds a Canada Research Chair in Viral Pandemics. He completed his PhD in Microbiology and Immunology at the University of Western Ontario, followed by a postdoctoral fellowship in Virology at the Icahn School of Medicine at Mount Sinai in New York, NY under the mentorship of Dr. Peter Palese. He was recruited to McMaster University in 2014 and has authored over 90 peer-reviewed publications in leading journals. He has received several major awards and distinctions, including a CIHR New Investigator Award, the CIHR Bhagirath Singh Early Career Award in Infection and Immunity, and an Early Researcher Award from the Government of Ontario, and a Distinguished Alumni Award for Excellence in Basic Science from Western University. He was elected to the Royal Society of Canada College of New Scholars in 2024.
Dr. Miller’s research program is focused primarily on pandemic prevention, especially the development of broadly-protective vaccines, antibodies, and therapeutics. His team is also interesting in understanding the way that viral infections and the immune response contribute to genetic and neurodegenerative conditions (e.g., ALS). He sits the scientific advisory board of several companies. He is a member of the Canadian National Advisory Committee on Immunization (NACI) COVID-19 Working Group, H5Nx Highly Pathogenic Avian Influenza Working Group, and Committee to Advise on Tropical Medicine and Travel (CATMAT). He serves on the Public Health Agency of Canada Expert Panel on H5Nx Highly Pathogenic Avian Influenza (HPAI). He was elected Secretary-Treasurer of the Canadian Society for Virology from 2021-2022.
